Lycera
Manufacturing · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Dauphin, Pennsylvania, 17018, United Sta...Phone Number
(734) 233-3060Website
www.lycera.comRevenue
$6.9 MillionIndustry
About Lycera
Lycera is a biopharmaceutical company advancing novel treatments for cancer and autoimmune diseases based on a proprietary portfolio of small molecules designed primarily to either suppress or activate the immune response. The Company's world-class expertise in distinct, yet complementary, areas of research - immune metabolism, cell signaling and immune cell differentiation - has generated four wholly owned programs, including a lead product candidate to treat inflammatory bowel disease (LYC-30937) expected to enter clinical testing in the first half of 2015. In addition, Lycera has established two collaborations with partner Merck to discover, develop and commercialize small molecule therapies for autoimmune disorders. The Lycera leadership team possesses deep experience from drug discovery and development through commercialization and has established close relationships with renowned thought leaders and clinical researchers worldwide. Lead investors in Lycera include InterWest PartneRead more
SIC Code 28,283NAICS Code 32,325Show moreLycera Org Chart
Compare Similar Companies to Lycera
Compare insights from companies similar to Lycera, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Lycera Tech Stack
A closer look at the technologies used by Lycera
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Lycera
Sign Up For FreeTo access detailed company insights
Lycera is a biopharmaceutical company advancing novel treatments for cancer and autoimmune diseases based on a proprietary portfolio of small molecules designed primarily to either suppress or activate the immune response. The Company's world-class expertise in distinct, yet complementary, areas of research - immune metabolism, cell signaling and i... Read More